Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-17-042112
Filing Date
2017-06-28
Accepted
2017-06-28 16:14:49
Documents
1
Period of Report
2017-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4292
  Complete submission text file 0001209191-17-042112.txt   5756
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Issuer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 430 N. JUNO LANE JUNO BEACH FL 33406
Business Address
Michelon Francois Roger (Reporting) CIK: 0001691470 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37969 | Film No.: 17935382